Professor Sanjay Swaminathan

Professor Sanjay Swaminathan

Clinical Dean, Blacktown Clinical School,
School of Medicine



  • PhD University of New South Wales
  • BMEDSc Monash University
  • MBBS Monash University

Professional Memberships

  • Australasian Society of Clinical Immunology and Allergy (ASCIA) (2004 - 2024)
  • Fellow Royal Australasian College of Physicians (FRACP) (2008)
  • Fellow Royal College of Pathologists of Australasia (FRCPA) (2008)
  • American Academy of Allergy Asthma and Immunology (AAAAI) (2012 - 2024)


  • Allergic disorders
  • Autoimmunity
  • Vasculitis
  • Viral Infections
  • microRNAs

Organisational Unit (School / Division)

  • School of Medicine


Location: OFF
Off Campus

PLEASE NOTE: obtaining information from this Directory must be for the legitimate purposes of doing business with and within Western Sydney University, and must not be used for unsolicited bulk e-mailing (spamming) or similar purposes.


Journal Articles

  • Afrasiabi, A., Fewings, N., Schibeci, S., Keane, J., Booth, D., Parnell, G. and Swaminathan, S. (2021), 'The interaction of human and Epstein-Barr virus miRNAs with Multiple Sclerosis risk loci', International Journal of Molecular Sciences, vol 22, no 6 .
  • Keane, J., Afrasiabi, A., Schibeci, S., Swaminathan, S., Parnell, G. and Booth, D. (2021), 'The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype', EBioMedicine, vol 71 .
  • Ryan, J., Tieu, J., Bose, B., Francis, R., Gingold, M., Goh, L., Gray, J., Hill, C., Hissaria, P., Jahan, S., Langguth, D., Li, J., McLean-Tooke, A., Peh, C., Rahman, M., Sammel, T., Stamp, L., Street, M., Swaminathan, S., Wong, N. and Kitching, R. (2020), 'Formation of the Australia and New Zealand Vasculitis Society (ANZVASC) to improve the care of patients with vasculitis in Australian and New Zealand', Internal Medicine Journal, vol 50, no 7 , pp 781 - 783.
  • Afrasiabi, A., Parnell, G., Swaminathan, S., Stewart, G. and Booth, D. (2020), 'The interaction of multiple sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis', Scientific Reports, vol 10, no 1 .
  • Ong, L., Parnell, G., Afrasiabi, A., Stewart, G., Swaminathan, S. and Booth, D. (2020), 'Transcribed B lymphocyte genes and multiple sclerosis risk genes are underrepresented in Epstein-Barr Virus hypomethylated regions', Genes and Immunity, vol 21, no 2 , pp 91 - 99.
  • Afrasiabi, A., Parnell, G., Fewings, N., Schibeci, S., Basuki, M., Chandramohan, R., Zhou, Y., Taylor, B., Brown, D., Swaminathan, S., McKay, F., Stewart, G. and Booth, D. (2019), 'Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility', Genome Medicine, vol 11, no 1 .
  • Jiang, J., Keat, K. and Swaminathan, S. (2019), 'ANCA-associated vasculitis in inflammatory bowel disease', Digestive Diseases and Sciences, vol 64 , pp 3350 - 3354.
  • Van Der Poorten, D., McLeod, D., Ahlenstiel, G., Read, S., Kwok, A., Santhakumar, C., Bassan, M., Culican, S., Campbell, D., Wong, S., Evans, L., Jideh, B., Kane, A., Katelaris, C., Keat, K., Ko, Y., Lee, J., Limaye, S., Lin, M., Murad, A., Rafferty, M., Suan, D., Swaminathan, S., Riminton, S., Toong, C. and Berglund, L. (2018), 'Gastric cancer screening in common variable immunodeficiency', Journal of Clinical Immunology, vol 38, no 7 , pp 768 - 777.
  • Anantharajah, A., Vucic, S., Tarafdar, S., Vongsuvanh, R., Wilcken, N. and Swaminathan, S. (2017), 'Prominent subcutaneous oedema as a masquerading symptom of an underlying inflammatory myopathy', Internal Medicine Journal, vol 47, no 2 , pp 217 - 221.
  • Chandratilleke, D., Silvestrini, R., Culican, S., Campbell, D., Byth-Wilson, K., Swaminathan, S. and Lin, M. (2016), 'Comparison of two extractable nuclear antigen testing algorithms : ALBIA versus ELISA/line immunoassay', Pathology, vol 48, no 5 , pp 491 - 497.
  • Swaminathan, S., Qiu, J., Rupert, A., Hu, Z., Higgins, J., Dewar, R., Stevens, R., Rehm, C., Metcalf, J., Sherman, B., Baseler, M., Lane, H. and Imamichi, T. (2016), 'Interleukin-15 (IL-15) strongly correlates with increasing HIV-1 viremia and markers of inflammation', PLoS One, vol 11, no 11 .
  • Kong, B., Micklethwaite, K., Swaminathan, S., Kefford, R. and Carlino, M. (2016), 'Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma', Melanoma Research, vol 26, no 2 , pp 202 - 204.
  • Swaminathan, S., Hu, Z., Rupert, A., Higgins, J., Dewar, R., Stevens, R., Chen, Q., Rehm, C., Metcalf, J., Baseler, M., Lane, H. and Imamichi, T. (2014), 'Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection', PLoS One, vol 9, no 6 .
  • Swaminathan, S. and Kelleher, A. (2014), 'MicroRNA modulation of key targets associated with T cell exhaustion in HIV-1 infection', Current Opinion in HIV and AIDS, vol 9, no 5 , pp 464 - 471.
  • Swaminathan, S., Sui, H., Adelsberger, J., Chen, Q., Sneller, M., Migueles, S., Kottilil, S., Ober, A., Jones, S., Rehm, C., Lane, H. and Imamichi, T. (2014), 'HIV-1 treated patients with undetectable viral loads have lower levels of innate immune responses via cytosolic DNA sensing systems compared with healthy uninfected controls', Journal of AIDS and Clinical Research, vol 5, no 6 .
  • Young, S., Ojaimi, S., Dunckley, H., Douglas, M., Kok, J., Fulcher, D., Lin, M. and Swaminathan, S. (2014), 'Vancomycin-associated drug reaction with eosinophilia and systemic symptoms syndrome', Internal Medicine Journal, vol 44, no 7 , pp 694 - 696.
  • Seddiki, N., Brezar, V., Ruffin, N., Levy, Y. and Swaminathan, S. (2014), 'Role of miR-155 in the regulation of lymphocyte immune function and disease', Immunology, vol 142, no 1 , pp 32 - 38.
  • Chen, Q., Swaminathan, S., Yang, D., Dai, L., Sui, H., Yang, J., Hornung, R., Wang, Y., Huang, D., Hu, X., Lempicki, R. and Imamichi, T. (2013), 'Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway', PLoS One, vol 8, no 3 .
  • Swaminathan, S., Dai, L., Lane, H. and Imamichi, T. (2013), 'Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection', Cytokine and Growth Factor Reviews, vol 24, no 6 , pp 571 - 577.
  • Seddiki, N., Phetsouphanh, C., Swaminathan, S., Xu, Y., Rao, S., Li, J., Sutcliffe, E., Denyer, G., Finlayson, R., Gelgor, L., Cooper, D., Zaunders, J. and Kelleher, A. (2013), 'The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection', European Journal of Immunology, vol 43, no 2 , pp 510 - 520.
  • Swaminathan, S., Murray, D. and Kelleher, A. (2013), 'miRNAs and HIV : unforeseen determinants of host-pathogen interaction', Immunological Reviews, vol 254, no 1 , pp 265 - 280.
  • Swaminathan, S., Hu, X., Zheng, X., Kriga, Y., Shetty, J., Zhao, Y., Stephens, R., Tran, B., Baseler, M., Yang, J., Lempicki, R., Huang, D., Lane, H. and Imamichi, T. (2013), 'Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties', Biochemical and Biophysical Research Communications, vol 434, no 2 , pp 228 - 234.
  • Swaminathan, S., Suzuki, K., Seddiki, N., Kaplan, W., Cowley, M., Hood, C., Clancy, J., Murray, D., Mendez, C., Gelgor, L., Anderson, B., Roth, N., Cooper, D. and Kelleher, A. (2012), 'Differential regulation of the let-7 family of microRNAs in CD4+ T cells alters IL-10 expression', Journal of Immunology, vol 188, no 12 , pp 6238 - 6246.
  • Suzuki, K., Ishida, T., Yamagishi, M., Ahlenstiel, C., Swaminathan, S., Marks, K., Murray, D., McCartney, E., Beard, M., Alexander, M., Purcell, D., Cooper, D., Watanabe, T. and Kelleher, A. (2011), 'Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific', RNA Biology, vol 8, no 6 , pp 1035 - 1046.
  • Swaminathan, S., Goldblatt, F., Dugar, M., Gordon, T. and Roberts-Thomson, P. (2008), 'Prevalence of sicca symptoms in a South Australian cohort with systemic sclerosis', Internal Medicine Journal, vol 38, no 12 , pp 897 - 903.

Current Projects

Title: Risk factors of liver and gastrointestinal adverse events in patients treated with Ipilimumab + Nivolumab
  • Bristol-Myers Squibb Australia Pty Ltd.
Western Researchers: Golo Ahlenstiel, Sanjay Swaminathan and Scott Read
Years: 2022-01-07 - 2024-12-20
ID: P00027471

Western Sydney University

Locked Bag 1797
Penrith NSW 2751

Tel: +61 2 9852 5222

ABN 53 014 069 881
CRICOS Provider No: 00917k